Immunology of Infectious Disease News Volume 9.08 | Mar 3 2021

    0
    32






    IIDN 9.08 | Mar 3 2021


    Immunology of Infectious Disease News by STEMCELL Technologies
    Vol. 9.08 – 3 March, 2021
    TOP STORY

    A Trans-Complementation System for SARS-CoV-2 Recapitulates Authentic Viral Replication without Virulence

    Researchers report a trans-complementation system that produced single-round infectious SARS-CoV-2 that recapitulated authentic viral replication.
    [Cell]

    AbstractFull Article

    Virtual Conference Exhibition: Immunology
    PUBLICATIONSRanked by the impact factor of the journal

    Evidence of Escape of SARS-CoV-2 Variant B.1.351 from Natural and Vaccine Induced Sera

    The receptor binding domain mutations provided tighter ACE2 binding and widespread escape from monoclonal antibody neutralization largely driven by E484K although K417N and N501Y acted together against some important antibody classes.
    [Cell]

    AbstractFull Article

    Reduced Neutralization of SARS-CoV-2 B.1.1.7 Variant by Convalescent and Vaccine Sera

    Scientists examined the ability of B.1.1.7 to evade antibody responses elicited by natural SARS-CoV-2 infection or vaccination.
    [Cell]

    AbstractFull Article

    Deep Immune Profiling of MIS-C Demonstrates Marked but Transient Immune Activation Compared to Adult and Pediatric COVID-19

    Investigators analyzed peripheral blood immune responses in hospitalized SARS-CoV-2 infected pediatric patients and patients with Multisystem Inflammatory Syndrome in Children.
    [Science Immunology]

    Full Article

    Immunogenicity and Protective Efficacy of Inactivated SARS-CoV-2 Vaccine Candidate, BBV152 in Rhesus Macaques

    The authors developed and assessed the protective efficacy and immunogenicity of an inactivated SARS-CoV-2 vaccine in rhesus macaques.
    [Nature Communications]

    Full Article

    The Prevalence of Antibodies to SARS-CoV-2 among Blood Donors in China

    Scientists investigated the seroprevalence of SARS-CoV-2 antibodies among blood donors in the cities of Wuhan, Shenzhen, and Shijiazhuang in China.
    [Nature Communications]

    Full Article

    SARS-CoV-2 nsp12 Attenuates Type I Interferon Production by Inhibiting IRF3 Nuclear Translocation

    Researchers report that SARS-CoV-2 nsp12, the viral RNA-dependent RNA polymerase, suppressed host antiviral responses.
    [Cellular & Molecular Immunology]

    Full Article

    Metabolic Programs Define Dysfunctional Immune Responses in Severe COVID-19 Patients

    By interrogating metabolic programs of immune cells in severe and recovered COVID-19 patients compared to other viral infections, researchers identified a unique population of T cells.
    [Cell Reports]

    Abstract

    SARS-CoV-2 Engages Inflammasome and Pyroptosis in Human Primary Monocytes

    Scientists showed that SARS-CoV-2 engaged inflammasome and triggered pyroptosis in human monocytes, experimentally infected, and from patients under intensive care.
    [Cell Death Discovery]

    Full Article

    CD8+ T Cells Fail to Limit SIV Reactivation Following ART Withdrawal until after Viral Amplification

    The authors determined the effect of long-term CD8+ T cell depletion using a rhesusized anti-CD8β monoclonal antibody on barcoded SIVmac239 dynamics on stable ART.
    [Journal of Clinical Investigation]

    AbstractFull Article

    LL-37-Mediated Activation of Host Receptors Is Critical for Defense against Group A Streptococcal Infection

    Researchers showed that Group A Streptococcus extracellular protease ScpC N-terminally cleaved LL-37 into two fragments of 8 and 29 amino acids, preserving its bactericidal activity.
    [Cell Reports]

    Full ArticleGraphical Abstract

    Interleukin-33 Signaling Exacerbates Experimental Infectious Colitis by Enhancing Gut Permeability and Inhibiting Protective Th17 Immunity

    Investigators identified IL-33 as a critical regulator of the immune response to the enteric pathogen Citrobacter rodentium.
    [Mucosal Immunology]

    Full Article

    Next Generation Methodology for Updating Ha Vaccines against Emerging Human Seasonal Influenza A(H3N2) Viruses

    Building upon the COBRA technology, nine next-generation H3N2 influenza hemagglutinin (HA) vaccines were designed using a next generation algorithm and design methodology.
    [Scientific Reports]

    Full Article

    Explore scientific events this March with the Science Events Calendar.
    REVIEWS

    Toxoplasma gondii Infection and Its Implications within the Central Nervous System

    Scientists explore some of these recent findings that extend our understanding for proliferation, establishment and control of toxoplasmosis in humans.
    [Nature Reviews Microbiology]

    Abstract

    The Variant Gambit: COVID’s Next Move

    The authors outline factors driving SARS-CoV-2 variant evolution, explore the potential impact of specific mutations, examine the risk of further mutations.
    [Cell Host & Microbe]

    Abstract

    SARS-CoV-2 Vaccines Strategies: A Comprehensive Review of Phase III Candidates

    Different vaccine platforms are being used for vaccine development, each one presenting several advantages and disadvantages.
    [npj Vaccines]

    Full Article

    INDUSTRY AND POLICY NEWS

    Peter Lougheed Centre Joins the Phase II Trial of LSALT Peptide for the Treatment of Complications in Hospitalized COVID-19 Patients

    Arch Biopartners, Inc. announced that the Peter Lougheed Center in Calgary, Alberta has joined the Phase II trial of its lead drug LSALT peptide, targeting the prevention of acute lung injury, acute kidney injury, and other complications caused by inflammation in hospitalized patients with moderate to severe cases of COVID-19.
    [Arch Biopartners, Inc.]

    Press Release

    FEATURED EVENT

    Malaria in the Era of COVID-19

    March 16 – 17, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Research Associate – COVID-19 Registry

    The University of British Columbia- Vancouver, British Columbia, Canada

    Assistant Professor – Infectious Diseases

    University of California Merced – Merced, California, United States

    Postdoctoral Fellow – Human COVID Immunology

    Oklahoma Medical Research Foundation – Oklahoma City, Oklahoma, United States

    Postdoctoral Researcher – 3D In Vitro Systems for Respiratory Bacterial Infections

    NCCR AntiResist – Basel, Switzerland

    Postdoctoral Position – M. tuberculosis Infection

    UT Health Science Center at Tyler – Tyler, Texas, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Immunology of Infectious Disease News Twitter